San Diego, CA, United States of America

Richard I Hogrefe

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Trilink Biotechnologies, Inc., Genta Incorporated, Solulink Incorporated. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard I Hogrefe. Retrieved from https://idiyas.com/inventor/richard-i-hogrefe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 94.4

 

 

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 179(Granted Patents)


Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Inventor Richard I Hogrefe

Introduction: Richard I Hogrefe is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Richard I Hogrefe holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Richard I Hogrefe has demonstrated a keen interest in developing cutting-edge solutions to complex challenges, earning him a reputation as a forward-thinker in the industry.

Collaborations: Richard I Hogrefe has collaborated with leading companies and research institutions to bring his inventions to life, further solidifying his position as a key player in the innovation landscape.

Conclusion: Richard I Hogrefe's passion for innovation and his dedication to pushing the boundaries of what is possible make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…